Second Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems—2008

This review was prepared in advance of the Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems that was held at the W Hotel in Chicago, Illinois, from November 1 through 3, 2018. The purpose of this conference was to evaluate the safety of intravenous (IV) infusion systems used for medication administration. The expert panel of pharmacists, physicians, and nurses updated the findings of the Second Consensus Development Conference in 2009 that reviewed 5 IV drug delivery systems (manufacturer ready to use, outsourced ready to use, point-of-care activated, pharmacy compounded, and nonpharmacy compounded at point of care) with regard to applicability, ease of use, regulatory compliance, cost, safety, and implementation. The Third Consensus Development Conference expanded on previous findings by reviewing proceedings related to new standards, legislation, technologies, and shortage-related challenges related to IV medication administration that have been published since 2009. Invited faculty and audience members participated in revising a preliminary report summarizing these changes during the meeting.

Download Full-text

The Safety of Intravenous Drug Delivery Systems: Update on Current Issues since the 1999 Consensus Development Conference

Hospital Pharmacy ◽

10.1310/hpj4402-159 ◽

2009 ◽

Vol 44 (2) ◽

pp. 159-164 ◽

Cited By ~ 3

Author(s):

Michael Sanborn ◽

Michael Gabay ◽

Mary Lynn Moody

Keyword(s):

Drug Delivery ◽

Drug Delivery Systems ◽

Delivery Systems ◽

Intravenous Drug ◽

Consensus Development ◽

Consensus Development Conference

Download Full-text

Consensus Development Conference Intravenou men Drug on the Safety Systems: Balancing Safety and Cost

Hospital Pharmacy ◽

10.1177/001857870003500213 ◽

2000 ◽

Vol 35 (2) ◽

pp. 150-155 ◽

Cited By ~ 9

Author(s):

David W. Bates ◽

Diane D. Cousins ◽

Elizabeth Flynn ◽

John W. Gosbee ◽

Linda Richason ◽

...

Keyword(s):

Drug Delivery ◽

Health Care ◽

Drug Delivery Systems ◽

Drug Distribution ◽

Cost Savings ◽

Delivery Systems ◽

Intravenous Drug ◽

Consensus Development ◽

Decision Matrix ◽

Consensus Development Conference

As cost-containment pressures on health care systems continue, traditional practices are searching for ways to deliver care less expensively. Intravenous drug delivery systems have become a targeted area for cost savings in many health care institutions because they are so extensively used. Benchmark systems that have been shown to improve safety, such as unit-dose drug distribution and IV admixture programs, are now being viewed as costly alternatives. Likewise, technologies and innovations that have the potential to improve efficiency and safety are being critically scrutinized. The decision matrix for selection of IV drug delivery systems needs to carefully balance cost, quality, efficiency, and safety—relative to the medication use process as a whole. This article presents the final statement of the Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems, held on September 27–28, 1999, in Phoenix, AZ. The purpose of the conference was to provide a balanced assessment of available IV drug delivery systems.

Download Full-text

Intravenous drug delivery systems: Toward an intravenous “vaporizer”

Journal of Clinical Anesthesia ◽

10.1016/s0952-8180(96)90005-7 ◽

1996 ◽

Vol 8 (3) ◽

pp. S8-S14 ◽

Cited By ~ 19

Author(s):

Talmage D. Egan

Keyword(s):

Drug Delivery ◽

Drug Delivery Systems ◽

Delivery Systems ◽

Intravenous Drug

Download Full-text

Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems—2018

American Journal of Health-System Pharmacy ◽

10.1093/ajhp/zxz277 ◽

2019 ◽

Vol 77 (3) ◽

pp. 215-220

Author(s):

Michael Gabay ◽

John B Hertig ◽

Dan Degnan ◽

Maureen Burger ◽

Angela Yaniv ◽

...

Keyword(s):

Drug Delivery ◽

Drug Delivery Systems ◽

Expert Panel ◽

Healthcare Providers ◽

Delivery Systems ◽

Consensus Conference ◽

Intravenous Drug ◽

Drug Shortages ◽

The Third ◽

The Impact

Abstract Purpose The Third Consensus Conference on the Safety of Intravenous Drug Delivery Systems was convened to evaluate the benefits and risks of available systems and assess ongoing threats to the safety of intravenous drug delivery. Summary The Third Consensus Conference on the Safety of Intravenous Drug Delivery Systems convened in Chicago, Illinois in November 2018. An expert panel of healthcare providers with experience in medication quality and safety, pharmacy and nursing operations, information technology, and/or sterile compounding led the conference. An experienced audience of approximately 30 healthcare leaders provided feedback to the panel via preconference survey and during the conference. Additionally, expert speakers presented on a range of issues, including the effects of drug shortages, the impact of standards and guidelines, and patient and administrator perspectives on the importance of intravenous drug delivery safety. Conclusion At the end of the conference, the expert panel concluded that manufacturer ready-to-use products remain the safest intravenous drug delivery system due to their many benefits and low overall risk profile. The panel identified various ongoing threats to the safety of intravenous drug delivery, with major concerns including the impact of drug shortages and lack of intravenous product standardization. Finally, the panel agreed upon a series of statements designed to advance the safety of intravenous drug delivery in healthcare institutions.

Download Full-text